Loading…
Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion
The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are...
Saved in:
Published in: | Diabetes & metabolic syndrome clinical research & reviews 2021-01, Vol.15 (1), p.55-62 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c403t-ea700fbed795fa57ae747b3aea0a03ebd8d96e1dc2cace35ef6d8f39fbae15413 |
container_end_page | 62 |
container_issue | 1 |
container_start_page | 55 |
container_title | Diabetes & metabolic syndrome clinical research & reviews |
container_volume | 15 |
creator | Das, Ashok Kumar Kalra, Sanjay B, Krishnakumar Sharma, Kamal John, Mathew Nair, Tiny Shaikh, Shehla Khandelwal, Deepak Priya, Gagan Dutta, Deep Gangadhar, Prathosh Dhingra, Atul Tiwaskar, Mangesh Shukla, Rishi Das, Sambit Baruah, Manash Pratim Gangopadhyay, Kalyan Kumar Ramakrishnan, Santosh Deshmukh, Vaishali Dasgupta, Arundhati Kumar, GVijaya Pandey, Neelam Joshi, Amya Surana, Vineet Kumar Punyani, Hitesh Shah, Parag Rattan, Aditya Chandrasekaran, Sruti Asirwatham, Arthur |
description | The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment’s (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints.
The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion.
The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic.
The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.
•Healthcare challenges during the pandemic are linked to resource constraints including shortage of PPE, laboratory tests and medications•A group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19•The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions•This will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic. |
doi_str_mv | 10.1016/j.dsx.2020.11.014 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7677048</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1871402120304793</els_id><sourcerecordid>2470026934</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-ea700fbed795fa57ae747b3aea0a03ebd8d96e1dc2cace35ef6d8f39fbae15413</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EoqXwAbggH7lksWMnTkBCQuFfpUq9AFdrYk92vXLiYCer9sonx8u2FVw42Z73m-fRPEJecrbhjNdv9hubbjYlK_ObbxiXj8g5b1RTMCHk4z93XkhW8jPyLKU9Y1XVlu1TciaEyAZKnZNfHUTrwogL9ME7Qw9u6zxMBqmbaHf94_JjwVsKk6URU1hjFnZr6nMh3h6R-2phduA9Tlu0dHEjpre0825yBjydI5jFZYb2kLKONzPGhYY562F6Tp4M4BO-uDsvyPfPn751X4ur6y-X3YerwkgmlgJBMTb0aFVbDVApQCVVLwCBARPY28a2NXJrSgMGRYVDbZtBtEMPyCvJxQV5f_Kd135Ea3BaIng9RzdCvNUBnP5XmdxOb8NBq1opJpts8PrOIIafK6ZFjy4Z9HldGNakS5knLOtWyIzyE2piSCni8PANZ_qYnd7rnJ0-Zqc51zm73PPq7_keOu7DysC7E4B5SweHUSfjMEdlXUSzaBvcf-x_A9XIro8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2470026934</pqid></control><display><type>article</type><title>Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion</title><source>Elsevier</source><creator>Das, Ashok Kumar ; Kalra, Sanjay ; B, Krishnakumar ; Sharma, Kamal ; John, Mathew ; Nair, Tiny ; Shaikh, Shehla ; Khandelwal, Deepak ; Priya, Gagan ; Dutta, Deep ; Gangadhar, Prathosh ; Dhingra, Atul ; Tiwaskar, Mangesh ; Shukla, Rishi ; Das, Sambit ; Baruah, Manash Pratim ; Gangopadhyay, Kalyan Kumar ; Ramakrishnan, Santosh ; Deshmukh, Vaishali ; Dasgupta, Arundhati ; Kumar, GVijaya ; Pandey, Neelam ; Joshi, Amya ; Surana, Vineet Kumar ; Punyani, Hitesh ; Shah, Parag ; Rattan, Aditya ; Chandrasekaran, Sruti ; Asirwatham, Arthur</creator><creatorcontrib>Das, Ashok Kumar ; Kalra, Sanjay ; B, Krishnakumar ; Sharma, Kamal ; John, Mathew ; Nair, Tiny ; Shaikh, Shehla ; Khandelwal, Deepak ; Priya, Gagan ; Dutta, Deep ; Gangadhar, Prathosh ; Dhingra, Atul ; Tiwaskar, Mangesh ; Shukla, Rishi ; Das, Sambit ; Baruah, Manash Pratim ; Gangopadhyay, Kalyan Kumar ; Ramakrishnan, Santosh ; Deshmukh, Vaishali ; Dasgupta, Arundhati ; Kumar, GVijaya ; Pandey, Neelam ; Joshi, Amya ; Surana, Vineet Kumar ; Punyani, Hitesh ; Shah, Parag ; Rattan, Aditya ; Chandrasekaran, Sruti ; Asirwatham, Arthur</creatorcontrib><description>The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment’s (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints.
The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion.
The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic.
The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.
•Healthcare challenges during the pandemic are linked to resource constraints including shortage of PPE, laboratory tests and medications•A group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19•The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions•This will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.</description><identifier>ISSN: 1871-4021</identifier><identifier>ISSN: 1878-0334</identifier><identifier>EISSN: 1878-0334</identifier><identifier>DOI: 10.1016/j.dsx.2020.11.014</identifier><identifier>PMID: 33310177</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Blood Glucose - drug effects ; Blood Glucose - metabolism ; Cardiometabolic vigilance ; Cardiotonic Agents - therapeutic use ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - drug therapy ; Cardiovascular Diseases - epidemiology ; COVID-19 - diagnosis ; COVID-19 - epidemiology ; COVID-19 - prevention & control ; COVID-19 resource husbandry ; Diabetes mellitus ; Health Resources - trends ; Humans ; Hypertension ; Hypertension - diagnosis ; Hypertension - drug therapy ; Hypertension - epidemiology ; Hypoglycemic Agents - pharmacology ; Hypoglycemic Agents - therapeutic use ; India - epidemiology ; Metabolic Diseases - diagnosis ; Metabolic Diseases - drug therapy ; Metabolic Diseases - epidemiology</subject><ispartof>Diabetes & metabolic syndrome clinical research & reviews, 2021-01, Vol.15 (1), p.55-62</ispartof><rights>2020 Diabetes India</rights><rights>Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.</rights><rights>2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. 2020 Diabetes India</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c403t-ea700fbed795fa57ae747b3aea0a03ebd8d96e1dc2cace35ef6d8f39fbae15413</cites><orcidid>0000-0002-2696-1534 ; 0000-0002-6435-7995 ; 0000-0003-4915-8805 ; 0000-0002-3193-977X ; 0000-0001-5983-0453</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33310177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Das, Ashok Kumar</creatorcontrib><creatorcontrib>Kalra, Sanjay</creatorcontrib><creatorcontrib>B, Krishnakumar</creatorcontrib><creatorcontrib>Sharma, Kamal</creatorcontrib><creatorcontrib>John, Mathew</creatorcontrib><creatorcontrib>Nair, Tiny</creatorcontrib><creatorcontrib>Shaikh, Shehla</creatorcontrib><creatorcontrib>Khandelwal, Deepak</creatorcontrib><creatorcontrib>Priya, Gagan</creatorcontrib><creatorcontrib>Dutta, Deep</creatorcontrib><creatorcontrib>Gangadhar, Prathosh</creatorcontrib><creatorcontrib>Dhingra, Atul</creatorcontrib><creatorcontrib>Tiwaskar, Mangesh</creatorcontrib><creatorcontrib>Shukla, Rishi</creatorcontrib><creatorcontrib>Das, Sambit</creatorcontrib><creatorcontrib>Baruah, Manash Pratim</creatorcontrib><creatorcontrib>Gangopadhyay, Kalyan Kumar</creatorcontrib><creatorcontrib>Ramakrishnan, Santosh</creatorcontrib><creatorcontrib>Deshmukh, Vaishali</creatorcontrib><creatorcontrib>Dasgupta, Arundhati</creatorcontrib><creatorcontrib>Kumar, GVijaya</creatorcontrib><creatorcontrib>Pandey, Neelam</creatorcontrib><creatorcontrib>Joshi, Amya</creatorcontrib><creatorcontrib>Surana, Vineet Kumar</creatorcontrib><creatorcontrib>Punyani, Hitesh</creatorcontrib><creatorcontrib>Shah, Parag</creatorcontrib><creatorcontrib>Rattan, Aditya</creatorcontrib><creatorcontrib>Chandrasekaran, Sruti</creatorcontrib><creatorcontrib>Asirwatham, Arthur</creatorcontrib><title>Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion</title><title>Diabetes & metabolic syndrome clinical research & reviews</title><addtitle>Diabetes Metab Syndr</addtitle><description>The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment’s (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints.
The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion.
The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic.
The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.
•Healthcare challenges during the pandemic are linked to resource constraints including shortage of PPE, laboratory tests and medications•A group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19•The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions•This will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.</description><subject>Blood Glucose - drug effects</subject><subject>Blood Glucose - metabolism</subject><subject>Cardiometabolic vigilance</subject><subject>Cardiotonic Agents - therapeutic use</subject><subject>Cardiovascular Diseases - diagnosis</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 resource husbandry</subject><subject>Diabetes mellitus</subject><subject>Health Resources - trends</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - diagnosis</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>India - epidemiology</subject><subject>Metabolic Diseases - diagnosis</subject><subject>Metabolic Diseases - drug therapy</subject><subject>Metabolic Diseases - epidemiology</subject><issn>1871-4021</issn><issn>1878-0334</issn><issn>1878-0334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kU9v1DAQxS0EoqXwAbggH7lksWMnTkBCQuFfpUq9AFdrYk92vXLiYCer9sonx8u2FVw42Z73m-fRPEJecrbhjNdv9hubbjYlK_ObbxiXj8g5b1RTMCHk4z93XkhW8jPyLKU9Y1XVlu1TciaEyAZKnZNfHUTrwogL9ME7Qw9u6zxMBqmbaHf94_JjwVsKk6URU1hjFnZr6nMh3h6R-2phduA9Tlu0dHEjpre0825yBjydI5jFZYb2kLKONzPGhYY562F6Tp4M4BO-uDsvyPfPn751X4ur6y-X3YerwkgmlgJBMTb0aFVbDVApQCVVLwCBARPY28a2NXJrSgMGRYVDbZtBtEMPyCvJxQV5f_Kd135Ea3BaIng9RzdCvNUBnP5XmdxOb8NBq1opJpts8PrOIIafK6ZFjy4Z9HldGNakS5knLOtWyIzyE2piSCni8PANZ_qYnd7rnJ0-Zqc51zm73PPq7_keOu7DysC7E4B5SweHUSfjMEdlXUSzaBvcf-x_A9XIro8</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Das, Ashok Kumar</creator><creator>Kalra, Sanjay</creator><creator>B, Krishnakumar</creator><creator>Sharma, Kamal</creator><creator>John, Mathew</creator><creator>Nair, Tiny</creator><creator>Shaikh, Shehla</creator><creator>Khandelwal, Deepak</creator><creator>Priya, Gagan</creator><creator>Dutta, Deep</creator><creator>Gangadhar, Prathosh</creator><creator>Dhingra, Atul</creator><creator>Tiwaskar, Mangesh</creator><creator>Shukla, Rishi</creator><creator>Das, Sambit</creator><creator>Baruah, Manash Pratim</creator><creator>Gangopadhyay, Kalyan Kumar</creator><creator>Ramakrishnan, Santosh</creator><creator>Deshmukh, Vaishali</creator><creator>Dasgupta, Arundhati</creator><creator>Kumar, GVijaya</creator><creator>Pandey, Neelam</creator><creator>Joshi, Amya</creator><creator>Surana, Vineet Kumar</creator><creator>Punyani, Hitesh</creator><creator>Shah, Parag</creator><creator>Rattan, Aditya</creator><creator>Chandrasekaran, Sruti</creator><creator>Asirwatham, Arthur</creator><general>Elsevier Ltd</general><general>Diabetes India. Published by Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2696-1534</orcidid><orcidid>https://orcid.org/0000-0002-6435-7995</orcidid><orcidid>https://orcid.org/0000-0003-4915-8805</orcidid><orcidid>https://orcid.org/0000-0002-3193-977X</orcidid><orcidid>https://orcid.org/0000-0001-5983-0453</orcidid></search><sort><creationdate>20210101</creationdate><title>Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion</title><author>Das, Ashok Kumar ; Kalra, Sanjay ; B, Krishnakumar ; Sharma, Kamal ; John, Mathew ; Nair, Tiny ; Shaikh, Shehla ; Khandelwal, Deepak ; Priya, Gagan ; Dutta, Deep ; Gangadhar, Prathosh ; Dhingra, Atul ; Tiwaskar, Mangesh ; Shukla, Rishi ; Das, Sambit ; Baruah, Manash Pratim ; Gangopadhyay, Kalyan Kumar ; Ramakrishnan, Santosh ; Deshmukh, Vaishali ; Dasgupta, Arundhati ; Kumar, GVijaya ; Pandey, Neelam ; Joshi, Amya ; Surana, Vineet Kumar ; Punyani, Hitesh ; Shah, Parag ; Rattan, Aditya ; Chandrasekaran, Sruti ; Asirwatham, Arthur</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-ea700fbed795fa57ae747b3aea0a03ebd8d96e1dc2cace35ef6d8f39fbae15413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Blood Glucose - drug effects</topic><topic>Blood Glucose - metabolism</topic><topic>Cardiometabolic vigilance</topic><topic>Cardiotonic Agents - therapeutic use</topic><topic>Cardiovascular Diseases - diagnosis</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 resource husbandry</topic><topic>Diabetes mellitus</topic><topic>Health Resources - trends</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - diagnosis</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>India - epidemiology</topic><topic>Metabolic Diseases - diagnosis</topic><topic>Metabolic Diseases - drug therapy</topic><topic>Metabolic Diseases - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Das, Ashok Kumar</creatorcontrib><creatorcontrib>Kalra, Sanjay</creatorcontrib><creatorcontrib>B, Krishnakumar</creatorcontrib><creatorcontrib>Sharma, Kamal</creatorcontrib><creatorcontrib>John, Mathew</creatorcontrib><creatorcontrib>Nair, Tiny</creatorcontrib><creatorcontrib>Shaikh, Shehla</creatorcontrib><creatorcontrib>Khandelwal, Deepak</creatorcontrib><creatorcontrib>Priya, Gagan</creatorcontrib><creatorcontrib>Dutta, Deep</creatorcontrib><creatorcontrib>Gangadhar, Prathosh</creatorcontrib><creatorcontrib>Dhingra, Atul</creatorcontrib><creatorcontrib>Tiwaskar, Mangesh</creatorcontrib><creatorcontrib>Shukla, Rishi</creatorcontrib><creatorcontrib>Das, Sambit</creatorcontrib><creatorcontrib>Baruah, Manash Pratim</creatorcontrib><creatorcontrib>Gangopadhyay, Kalyan Kumar</creatorcontrib><creatorcontrib>Ramakrishnan, Santosh</creatorcontrib><creatorcontrib>Deshmukh, Vaishali</creatorcontrib><creatorcontrib>Dasgupta, Arundhati</creatorcontrib><creatorcontrib>Kumar, GVijaya</creatorcontrib><creatorcontrib>Pandey, Neelam</creatorcontrib><creatorcontrib>Joshi, Amya</creatorcontrib><creatorcontrib>Surana, Vineet Kumar</creatorcontrib><creatorcontrib>Punyani, Hitesh</creatorcontrib><creatorcontrib>Shah, Parag</creatorcontrib><creatorcontrib>Rattan, Aditya</creatorcontrib><creatorcontrib>Chandrasekaran, Sruti</creatorcontrib><creatorcontrib>Asirwatham, Arthur</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes & metabolic syndrome clinical research & reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Das, Ashok Kumar</au><au>Kalra, Sanjay</au><au>B, Krishnakumar</au><au>Sharma, Kamal</au><au>John, Mathew</au><au>Nair, Tiny</au><au>Shaikh, Shehla</au><au>Khandelwal, Deepak</au><au>Priya, Gagan</au><au>Dutta, Deep</au><au>Gangadhar, Prathosh</au><au>Dhingra, Atul</au><au>Tiwaskar, Mangesh</au><au>Shukla, Rishi</au><au>Das, Sambit</au><au>Baruah, Manash Pratim</au><au>Gangopadhyay, Kalyan Kumar</au><au>Ramakrishnan, Santosh</au><au>Deshmukh, Vaishali</au><au>Dasgupta, Arundhati</au><au>Kumar, GVijaya</au><au>Pandey, Neelam</au><au>Joshi, Amya</au><au>Surana, Vineet Kumar</au><au>Punyani, Hitesh</au><au>Shah, Parag</au><au>Rattan, Aditya</au><au>Chandrasekaran, Sruti</au><au>Asirwatham, Arthur</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion</atitle><jtitle>Diabetes & metabolic syndrome clinical research & reviews</jtitle><addtitle>Diabetes Metab Syndr</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>15</volume><issue>1</issue><spage>55</spage><epage>62</epage><pages>55-62</pages><issn>1871-4021</issn><issn>1878-0334</issn><eissn>1878-0334</eissn><abstract>The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment’s (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints.
The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion.
The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic.
The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.
•Healthcare challenges during the pandemic are linked to resource constraints including shortage of PPE, laboratory tests and medications•A group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19•The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions•This will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33310177</pmid><doi>10.1016/j.dsx.2020.11.014</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-2696-1534</orcidid><orcidid>https://orcid.org/0000-0002-6435-7995</orcidid><orcidid>https://orcid.org/0000-0003-4915-8805</orcidid><orcidid>https://orcid.org/0000-0002-3193-977X</orcidid><orcidid>https://orcid.org/0000-0001-5983-0453</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1871-4021 |
ispartof | Diabetes & metabolic syndrome clinical research & reviews, 2021-01, Vol.15 (1), p.55-62 |
issn | 1871-4021 1878-0334 1878-0334 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7677048 |
source | Elsevier |
subjects | Blood Glucose - drug effects Blood Glucose - metabolism Cardiometabolic vigilance Cardiotonic Agents - therapeutic use Cardiovascular Diseases - diagnosis Cardiovascular Diseases - drug therapy Cardiovascular Diseases - epidemiology COVID-19 - diagnosis COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 resource husbandry Diabetes mellitus Health Resources - trends Humans Hypertension Hypertension - diagnosis Hypertension - drug therapy Hypertension - epidemiology Hypoglycemic Agents - pharmacology Hypoglycemic Agents - therapeutic use India - epidemiology Metabolic Diseases - diagnosis Metabolic Diseases - drug therapy Metabolic Diseases - epidemiology |
title | Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A59%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiometabolic%20vigilance%20in%20COVID-19%20and%20resource%20husbandry%20in%20resource-challenged%20times:%20Clinical%20practice-%20based%20expert%20opinion&rft.jtitle=Diabetes%20&%20metabolic%20syndrome%20clinical%20research%20&%20reviews&rft.au=Das,%20Ashok%20Kumar&rft.date=2021-01-01&rft.volume=15&rft.issue=1&rft.spage=55&rft.epage=62&rft.pages=55-62&rft.issn=1871-4021&rft.eissn=1878-0334&rft_id=info:doi/10.1016/j.dsx.2020.11.014&rft_dat=%3Cproquest_pubme%3E2470026934%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c403t-ea700fbed795fa57ae747b3aea0a03ebd8d96e1dc2cace35ef6d8f39fbae15413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2470026934&rft_id=info:pmid/33310177&rfr_iscdi=true |